During the past decade, Burzynski Clinic conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 29 clinical trials were completed, i.e. on average, 2900% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Burzynski Clinic" are "Stage IV Breast Cancer" (3 trials), "Stage IV Lung Cancer" (3 trials), "Non-hodgkins Lymphoma" (2 trials), "Recurrent Breast Cancer" (2 trials) and "Stage IV Prostate Cancer" (2 trials). Many other conditions were trialed in "Burzynski Clinic" in a lesser frequency.

Most popular intervention types in "Burzynski Clinic" are "Drug" (62 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Antineoplaston therapy (Atengenal + Astugenal)" (53 trials), "alternative product therapy" (7 trials), "antineoplaston A10" (7 trials), "biological therapy" (7 trials) and "biologically based therapies" (7 trials). Other intervention names were less common.

The vast majority of trials in "Burzynski Clinic" are 56 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Burzynski Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Burzynski Clinic, 1 suspended trials, and 39 terminated clinical trials to date.

Out of the total trials that were conducted in Burzynski Clinic, 0 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".